Literature DB >> 31748919

The SIFK score: a validated predictive model for arthroplasty progression after subchondral insufficiency fractures of the knee.

Ayoosh Pareek1, Chad W Parkes1, Christopher D Bernard1, Matthew P Abdel1, Daniel B F Saris1, Aaron J Krych2.   

Abstract

PURPOSE: The purpose of this study was to create a predictive model utilizing baseline demographic and radiographic characteristics for the likelihood that a patient with subchondral insufficiency fracture of the knee will progress to knee arthroplasty with emphasis on clinical interpretability and usability.
METHODS: A retrospective review of baseline and final radiographs in addition to MRIs were reviewed for evaluation of insufficiency fractures and associated injuries. Patient and radiographic factors were used in building predictive models for progression to arthroplasty with Train: Validation: Test subsets. Multiple models were compared with emphasis on clinical utility.
RESULTS: Total of 249 patients with a mean age of 64.6 (SD 10.5) years were included. Knee arthroplasty rate was 27% at mean of 4 years of follow-up. Lasso Regression was non-inferior to other models and was chosen for ease of interpretability. In order of importance, predictors for progression to arthroplasty included lateral meniscus extrusion, Kellgren-Lawrence Grade 4, SIFK on MFC, lateral meniscus root tear, and medial meniscus extrusion. The final SIFK Score stratified patients into low-, medium-, and high-risk categories with arthroplasty rates of 8.8%, 40.4%, and 78.9% (p < 0.001) and an area under the curve of 82.5%.
CONCLUSION: In this validated model, lateral meniscus extrusion, K-L Grade 4, SIFK on MFC, lateral meniscus root tear, and medial meniscus extrusion were the most important factors in predicting progression to arthroplasty (in that order). This model assists in patient treatment and counseling in providing prognostic information based on patient-specific risk factors by classifying them into a low-, medium-, and high-risk categories. This model can be used both by medical professionals treating musculoskeletal injuries in guiding patient decision making. LEVEL OF EVIDENCE: Level III.

Entities:  

Keywords:  Machine learning; Meniscus extrusion; Meniscus tear; Predictive model; Root; SONK; SPONK; Spontaneous osteonecrosis; Subchondral insufficiency fracture

Mesh:

Year:  2019        PMID: 31748919     DOI: 10.1007/s00167-019-05792-w

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  5 in total

Review 1.  Current Reviews in Musculoskeletal Medicine: Current Controversies for Treatment of Meniscus Root Tears.

Authors:  Dustin R Lee; Anna K Reinholz; Sara E Till; Yining Lu; Christopher L Camp; Thomas M DeBerardino; Michael J Stuart; Aaron J Krych
Journal:  Curr Rev Musculoskelet Med       Date:  2022-04-27

2.  A Machine Learning Algorithm Outperforms Traditional Multiple Regression to Predict Risk of Unplanned Overnight Stay Following Outpatient Medial Patellofemoral Ligament Reconstruction.

Authors:  Chimere O Ezuma; Yining Lu; Ayoosh Pareek; Ryan Wilbur; Aaron J Krych; Brian Forsythe; Christopher L Camp
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-05-24

3.  Artificial intelligence and machine learning: an introduction for orthopaedic surgeons.

Authors:  R Kyle Martin; Christophe Ley; Ayoosh Pareek; Andreas Groll; Thomas Tischer; Romain Seil
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2021-09-15       Impact factor: 4.114

4.  Artificial Learning and Machine Learning Decision Guidance Applications in Total Hip and Knee Arthroplasty: A Systematic Review.

Authors:  Cesar D Lopez; Anastasia Gazgalis; Venkat Boddapati; Roshan P Shah; H John Cooper; Jeffrey A Geller
Journal:  Arthroplast Today       Date:  2021-09-03

5.  Early tibial component loosening of medial UKA after severe medial plateau SONK-report of three cases.

Authors:  Marcus Vinicius Danieli; João Paulo Fernandes Guerreiro; Alexandre Oliveira Queiroz; Guilherme José Miyasaki Piovesana
Journal:  J Surg Case Rep       Date:  2021-06-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.